Corvus Pharmaceuticals, Inc.
CRVS
$14.04
-$0.04-0.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.61% | -11.72% | 68.30% | -14.92% | 24.76% |
| Total Receivables | 8.09% | 33.59% | 14.10% | 5.09% | -2.26% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.42% | -33.03% | -34.32% | 7.87% | 21.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 33.67% | -12.16% | 43.30% | -68.98% | 165.81% |
| Total Current Assets | -13.04% | -11.66% | 66.58% | -16.39% | 26.76% |
|
|
|||||
| Total Current Assets | -13.04% | -11.66% | 66.58% | -16.39% | 26.76% |
| Net Property, Plant & Equipment | -7.75% | -8.96% | 0.08% | -5.12% | 191.87% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.35% | 36.10% | -0.48% | -0.47% | 150.79% |
| Total Assets | -11.62% | -10.05% | 50.51% | -13.74% | 17.16% |
|
|
|||||
| Total Accounts Payable | 26.19% | -37.07% | 139.83% | -49.34% | 37.85% |
| Total Accrued Expenses | 21.20% | 10.46% | 30.55% | 4.05% | -9.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.33% | 6.76% | 11.29% | 72.43% | -47.74% |
| Total Finance Division Other Current Liabilities | -57.95% | 63.58% | -91.51% | -86.04% | -27.66% |
| Total Other Current Liabilities | -57.95% | 63.58% | -91.51% | -86.04% | -27.66% |
| Total Current Liabilities | 16.18% | -5.07% | -8.34% | -73.79% | -23.71% |
|
|
|||||
| Total Current Liabilities | 16.18% | -5.07% | -8.34% | -73.79% | -23.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.51% | -13.19% | -12.71% | -10.99% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.88% | -5.71% | -8.70% | -72.17% | -21.69% |
|
|
|||||
| Common Stock & APIC | 0.34% | 0.34% | 8.97% | 0.36% | 8.25% |
| Retained Earnings | -3.08% | -2.61% | -2.09% | 3.83% | -3.15% |
| Treasury Stock & Other | 15.47% | 7.67% | 8.45% | 2.64% | -74.53% |
| Total Common Equity | -14.72% | -10.54% | 62.65% | 51.45% | 162.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.72% | -10.54% | 62.65% | 51.45% | 162.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.72% | -10.54% | 62.65% | 51.45% | 162.45% |
|
|
|||||